Reported figures and Equlion model projections for the next 5 years.
Metric
2025 (actual)
2026
2027
2028
2029
2030
Trend
ROE
-46.12%
-88.15%
-
115.75%
58.58%
38.99%
ROA
-40.09%
-68.06%
-170.5%
-392.29%
-404.21%
-403.02%
Gross Margin
100%
100%
100%
100%
100%
100%
Sector average
16.85%
17.71%
17.71%
17.71%
17.71%
17.71%
Net Margin
Amounts in SEK (thousands); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Stock price and valuation carry no data date: they are the Equlion model's estimate for 2025. Projections are model estimates, not investment advice.
Want the full financial forecast report for BioInvent International AB (publ)? It covers the balance sheet, income statement and Equlion model projections.
-146.96%
-146.91%
-147.61%
-148.58%
-149.33%
-149.7%
Total Assets
SEK 671,202.00K
SEK 331,375.68K
SEK 102,324.39K
SEK 112,410.22K
SEK 123,065.25K
SEK 129,412.11K
Sector average
SEK 2,857,190.78K
SEK 2,900,240.60K
SEK 3,045,009.79K
SEK 3,280,286.42K
SEK 3,536,407.14K
SEK 3,762,908.71K
Net Income
-SEK 332,858.00K
-SEK 341,159.97K
-SEK 369,727.10K
-SEK 421,193.99K
-SEK 475,904.36K
-SEK 508,769.77K
Sector average
-SEK 2,851.32K
-SEK 22,027.28K
-SEK 904.69K
-SEK 7,253.84K
-SEK 3,858.45K
-SEK 1,547.00K
Valuation
SEK 1,934,648.24K
SEK 1,982,901.22K
SEK 2,148,940.06K
SEK 2,448,077.60K
SEK 2,766,067.03K
SEK 2,957,088.41K
Sector average
SEK 3,960,502.41K
SEK 5,151,301.60K
SEK 5,189,236.02K
SEK 5,317,343.69K
SEK 5,514,329.75K
SEK 5,636,782.17K
Stock Price
SEK 29.40
SEK 30.13
SEK 32.66
SEK 37.20
SEK 42.03
SEK 44.94
Sector average
SEK 57.22
SEK 48.04
SEK 48.69
SEK 50.45
SEK 52.13
SEK 53.41
BioInvent International AB (publ) (BINV.ST) Financial Forecast | Equlion
